Anti-tumor effects of engineered mesenchymal stem cells in colon cancer model

References

• Deng S, Zhou Z, de Hoog GS, et al. Evaluation of two molecular techniques for rapid detection of the main dermatophytic agents of tinea capitis. Br J Dermatol. 2015;173(6):1494–1500. doi:10.1111/bjd.1415626342174
   PubMed Web of Science ®Google Scholar
• Conde J, Oliva N, Zhang Y, Artzi N. Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. Nat Mater. 2016;15(10):1128–1138. doi:10.1038/nmat470727454043
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. doi:10.3322/caac.2116623335087
   PubMed Web of Science ®Google Scholar
• Kucerova L, Matuskova M, Hlubinova K, Altanerova V, Altaner C. Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer. 2010;9:129. doi:10.1186/1476-4598-9-25420509882
   PubMed Web of Science ®Google Scholar
• Ren G, Chen X, Dong F, et al. Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Transl Med. 2012;1(1):51–58. doi:10.5966/sctm.2011-001923197640
   PubMed Web of Science ®Google Scholar
• Song C, Xiang J, Tang J, et al. Thymidine kinase gene modified bone marrow mesenchymal stem cells as vehicles for antitumor therapy. Hum Gene Ther. 2011;22(4):439–449. doi:10.1089/hum.2010.11620925460
   PubMed Web of Science ®Google Scholar
• Kuroda Y, Dezawa M. Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine. Anat Rec (Hoboken). 2014;297(1):98–110. doi:10.1002/ar.2279824293378
   PubMedGoogle Scholar
• Bianco P, Cao X, Frenette PS, et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med. 2013;19(1):35–42. doi:10.1038/nm.302823296015
   PubMed Web of Science ®Google Scholar
• Fazekasova H, Lechler R, Langford K, Lombardi G. Placenta-derived MSCs are partially immunogenic and less immunomodulatory than bone marrow-derived MSCs. J Tissue Eng Regen Med. 2011;5(9):684–694. doi:10.1002/term.36221953866
   PubMed Web of Science ®Google Scholar
• Ryu CH, Park KY, Kim SM, et al. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma. Biochem Biophys Res Commun. 2012;421(3):585–590. doi:10.1016/j.bbrc.2012.04.05022525671
   PubMed Web of Science ®Google Scholar
• Nowakowski A, Drela K, Rozycka J, Janowski M, Lukomska B. Engineered mesenchymal stem cells as an anti-cancer trojan horse. Stem Cells Dev. 2016;25(20):1513–1531. doi:10.1089/scd.2016.012027460260
   PubMed Web of Science ®Google Scholar
• Stuckey DW, Shah K. Stem cell-based therapies for cancer treatment: separating hope from hype. Nat Rev Cancer. 2014;14(10):683–691. doi:10.1038/nrc379825176333
   PubMed Web of Science ®Google Scholar
• Lou G, Song X, Yang F, et al. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. J Hematol Oncol. 2015;8:122. doi:10.1186/s13045-015-0220-726514126
   PubMed Web of Science ®Google Scholar
• Barcellos-de-Souza P, Gori V, Bambi F, Chiarugi P. Tumor microenvironment: bone marrow-mesenchymal stem cells as key players. Biochim Biophys Acta. 2013;1836(2):321–335. doi:10.1016/j.bbcan.2013.10.00424183942
   PubMed Web of Science ®Google Scholar
• Zischek C, Niess H, Ischenko I, et al. Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma. Ann Surg. 2009;250(5):747–753. doi:10.1097/SLA.0b013e3181bd62d019826249
   PubMed Web of Science ®Google Scholar
• Han I, Yun M, Kim EO, Kim B, Jung MH, Kim SH. Umbilical cord tissue-derived mesenchymal stem cells induce apoptosis in PC-3 prostate cancer cells through activation of JNK and downregulation of PI3K/AKT signaling. Stem Cell Res Ther. 2014;5. doi:10.1186/scrt443
   Web of Science ®Google Scholar
• Kucerova L, Zmajkovic J, Toro L, Skolekova S, Demkova L, Matuskova M. Tumor-driven molecular changes in human mesenchymal stromal cells. Cancer Microenviron. 2015;8(1):1–14. doi:10.1007/s12307-014-0151-9
   PubMedGoogle Scholar
• Hung SC, Deng WP, Yang WK, et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res. 2005;11(21):7749–7756. doi:10.1158/1078-0432.CCR-05-087616278396
   PubMed Web of Science ®Google Scholar
• Dwyer RM, Potter-Beirne SM, Harrington KA, et al. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res. 2007;13(17):5020–5027. doi:10.1158/1078-0432.CCR-07-073117785552
   PubMed Web of Science ®Google Scholar
• Bussard KM, Mutkus L, Stumpf K, Gomez-Manzano C, Marini FC. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res. 2016;18(1):84. doi:10.1186/s13058-016-0740-227515302
   PubMed Web of Science ®Google Scholar
• Kikuchi H, Yagi H, Hasegawa H, et al. Therapeutic potential of transgenic mesenchymal stem cells engineered to mediate anti-high mobility group box 1 activity: targeting of colon cancer. J Surg Res. 2014;190(1):134–143. doi:10.1016/j.jss.2014.02.04724679698
   PubMed Web of Science ®Google Scholar
• Cavarretta IT, Altanerova V, Matuskova M, Kucerova L, Culig Z, Altaner C. Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth. Mol Ther. 2010;18(1):223–231. doi:10.1038/mt.2009.23719844197
   PubMed Web of Science ®Google Scholar
• Mizuno S, Nakamura T. HGF-MET cascade, a key target for inhibiting cancer metastasis: the impact of NK4 discovery on cancer biology and therapeutics. Int J Mol Sci. 2013;14(1):888–919. doi:10.3390/ijms1401088823296269
   PubMed Web of Science ®Google Scholar
• Yan C, Song X, Yu W, et al. Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects. Tumour Biol. 2016;37(6):8425–8435. doi:10.1007/s13277-015-4746-726733169
   PubMedGoogle Scholar
• Cao H, Yang J, Yu J, et al. Therapeutic potential of transplanted placental mesenchymal stem cells in treating Chinese miniature pigs with acute liver failure. BMC Med. 2012;10:56. doi:10.1186/1741-7015-10-5622673529
   PubMed Web of Science ®Google Scholar
• Torsvik A, Bjerkvig R. Mesenchymal stem cell signaling in cancer progression. Cancer Treat Rev. 2013;39(2):180–188. doi:10.1016/j.ctrv.2012.03.00522494966
   PubMed Web of Science ®Google Scholar